UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma: A post-marketing surveillance

Allergology international, 2021-07, Vol.70 (3), p.319-326

2021

Volltextzugriff (PDF)

Real-world Safety and Efficacy of Indacaterol/Glycopyrronium in Japanese Patients with Chronic Obstructive Pulmonary Disease: A 52-week Post-marketing Surveillance

Internal Medicine, 2022/03/15, Vol.61(6), pp.789-800

2022

Volltextzugriff (PDF)

Real-world Safety and Efficacy of Indacaterol Maleate in Patients with Chronic Obstructive Pulmonary Disease: Evidence from the Long-term Post-marketing Surveillance in Japan

Internal Medicine, 2021/08/01, Vol.60(15), pp.2385-2394

2021

Volltextzugriff (PDF)

Assessment of asthma severity according to treatment steps in Japanese pediatric patients: a descriptive cross-sectional study using an administrative claims database

The Journal of asthma, 2021-12, Vol.58 (12), p.1574-1580

2021

Volltextzugriff (PDF)

Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma : A post-marketing surveillance

Allergology International, 2021-07, Vol.70 (3), p.319-326

2021

Volltextzugriff (PDF)

Uncontrolled asthma: a retrospective cohort study in Japanese patients newly prescribed with medium-/high-dose ICS/LABA

NPJ primary care respiratory medicine, 2021-03, Vol.31 (1), p.12-12, Article 12

2021

Volltextzugriff (PDF)

The soluble form of a disintegrin and metalloprotease 33 promotes angiogenesis: Implications for airway remodeling in asthma

Journal of allergy and clinical immunology, 2008-06, Vol.121 (6), p.1400-1406.e4

2008

Volltextzugriff (PDF)

Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian population

BMJ open respiratory research, 2021-03, Vol.8 (1), p.e000856

2021

Volltextzugriff (PDF)

Discovery and Characterization of Allosteric WNK Kinase Inhibitors

ACS chemical biology, 2016-12, Vol.11 (12), p.3338-3346

2016

Volltextzugriff (PDF)

COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in Japan

International journal of chronic obstructive pulmonary disease, 2018-01, Vol.13, p.2629-2641

2018

Volltextzugriff (PDF)

Effect of MMP/ADAM inhibitors on goblet cell hyperplasia in cultured human bronchial epithelial cells

Bioscience, biotechnology, and biochemistry, 2004-10, Vol.68 (10), p.2024-2031

2004

Volltextzugriff (PDF)

Clinical Characteristics, Health Care Resource Utilization, and Prescription Patterns of Japanese Patients with Physician-Diagnosed Allergic Rhinitis: A Secondary Use of Database Study

International archives of allergy and immunology, 2022-09, Vol.183 (9), p.953-966

2022

Volltextzugriff (PDF)

A Novel Human CC Chemokine, Eotaxin-3, Which Is Expressed in IL-4-Stimulated Vascular Endothelial Cells, Exhibits Potent Activity Toward Eosinophils

The Journal of immunology (1950), 1999-08, Vol.163 (3), p.1602-1610

1999

Volltextzugriff (PDF)

Prevalence and Clinical Characteristics of Patients with Moderate-to-Severe Asthma in Japan Using a JMDC Claims Database

International archives of allergy and immunology, 2023-07, Vol.184 (7), p.698-706

2023

Volltextzugriff (PDF)

Prevalence of food allergy increased 1.7 times in the past 10 years among Japanese patients below 6 years of age

Pediatric allergy and immunology, 2024-07, Vol.35 (7), p.e14192-n/a

2024

Volltextzugriff (PDF)

Prevalence of food allergy increased 1.7 times in the past 10years among Japanese patients below 6years of age

Pediatric allergy and immunology, 2024-07, Vol.35 (7)

2024

Volltextzugriff (PDF)

Prevalence of Uncontrolled Asthma despite Treatment with Medium- or High-Dose ICS/LABA Using Patient-Reported Outcomes in Japan: The KOCU (KnOwing the Controlled statUs of Asthma in Japan) Study

International archives of allergy and immunology, 2023-07, Vol.184 (7), p.656-667

2023

Volltextzugriff (PDF)

Prevalence of Uncontrolled Asthma despite Treatment with Medium- or High-Dose ICS/LABA Using Patient-Reported Outcomes in Japan: The KOCU

International archives of allergy and immunology, 2023-07, Vol.184 (7), p.656

2023

Volltextzugriff (PDF)

Cysteinyl leukotrienes synergize with growth factors to induce proliferation of human bronchial fibroblasts

Journal of allergy and clinical immunology, 2007, Vol.119 (1), p.132-140

2007

Volltextzugriff (PDF)

Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives

Advances in therapy, 2019-03, Vol.36 (3), p.495-519

2019

Volltextzugriff (PDF)

Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan

Respiratory medicine, 2018-08, Vol.141, p.56-63

2018

Volltextzugriff (PDF)

Real-world Safety and Efficacy of indacaterol Maleate in Patients with Chronic Obstructive Pulmonary Disease: Evidence from the Long-term Post-marketing Surveillance in Japan

Internal Medicine, 2021, pp.5571-20

2021

Volltextzugriff (PDF)

Real-world Safety and Efficacy of Indacaterol/Glycopyrronium in Japanese Patients with Chronic Obstructive Pulmonary Disease: A 52-week Post-marketing Surveillance

Internal Medicine, 2021, pp.7845-21

2021

Volltextzugriff (PDF)

Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long‐acting bronchodilator‐naïve COPD patients: A pooled analysis

Respirology (Carlton, Vic.), 2020-04, Vol.25 (4), p.393-400

2020

Volltextzugriff (PDF)

Real-World Safety and Efficacy of Glycopyrronium Bromide in Japanese Patients with COPD: A 52-Week Post-Marketing Surveillance

The open respiratory medicine journal, 2022, Vol.16 (1), p.e187430642112240-e187430642112240

2022

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(49)

Sprache

Englisch
(45)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Humans
(20)
Asthma
(12)
Allergy
(9)
Base Sequence
(9)
Biological And Medical Sciences
(9)
Immunology
(9)
Molecular Sequence Data
(9)
Respiratory System
(9)
Amino Acid Sequence
(8)
Fundamental And Applied Biological Sciences. Psychology
(8)
Post-Marketing Surveillance
(8)
Chronic Obstructive Pulmonary Disease
(7)
Copd
(7)
Male
(7)
Safety
(7)
Bacillus Thuringiensis
(6)
Bacillus Thuringiensis - Genetics
(6)
Bacterial Proteins - Genetics
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma: A post-marketing surveillance

Real-world Safety and Efficacy of Indacaterol/Glycopyrronium in Japanese Patients with Chronic Obstructive Pulmonary Disease: A 52-week Post-marketing Surveillance

Real-world Safety and Efficacy of Indacaterol Maleate in Patients with Chronic Obstructive Pulmonary Disease: Evidence from the Long-term Post-marketing Surveillance in Japan

Assessment of asthma severity according to treatment steps in Japanese pediatric patients: a descriptive cross-sectional study using an administrative claims database

Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma : A post-marketing surveillance

Uncontrolled asthma: a retrospective cohort study in Japanese patients newly prescribed with medium-/high-dose ICS/LABA

The soluble form of a disintegrin and metalloprotease 33 promotes angiogenesis: Implications for airway remodeling in asthma

Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian population

Discovery and Characterization of Allosteric WNK Kinase Inhibitors

COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in Japan

Effect of MMP/ADAM inhibitors on goblet cell hyperplasia in cultured human bronchial epithelial cells

Clinical Characteristics, Health Care Resource Utilization, and Prescription Patterns of Japanese Patients with Physician-Diagnosed Allergic Rhinitis: A Secondary Use of Database Study

A Novel Human CC Chemokine, Eotaxin-3, Which Is Expressed in IL-4-Stimulated Vascular Endothelial Cells, Exhibits Potent Activity Toward Eosinophils

Prevalence and Clinical Characteristics of Patients with Moderate-to-Severe Asthma in Japan Using a JMDC Claims Database

Prevalence of food allergy increased 1.7 times in the past 10 years among Japanese patients below 6 years of age

Prevalence of food allergy increased 1.7 times in the past 10years among Japanese patients below 6years of age

Prevalence of Uncontrolled Asthma despite Treatment with Medium- or High-Dose ICS/LABA Using Patient-Reported Outcomes in Japan: The KOCU (KnOwing the Controlled statUs of Asthma in Japan) Study

Prevalence of Uncontrolled Asthma despite Treatment with Medium- or High-Dose ICS/LABA Using Patient-Reported Outcomes in Japan: The KOCU

Cysteinyl leukotrienes synergize with growth factors to induce proliferation of human bronchial fibroblasts

Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives

Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan

Real-world Safety and Efficacy of indacaterol Maleate in Patients with Chronic Obstructive Pulmonary Disease: Evidence from the Long-term Post-marketing Surveillance in Japan

Real-world Safety and Efficacy of Indacaterol/Glycopyrronium in Japanese Patients with Chronic Obstructive Pulmonary Disease: A 52-week Post-marketing Surveillance

Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long‐acting bronchodilator‐naïve COPD patients: A pooled analysis

Real-World Safety and Efficacy of Glycopyrronium Bromide in Japanese Patients with COPD: A 52-Week Post-Marketing Surveillance

Suchergebnisse filtern